Glenmark Life Sciences Dividend
What is Glenmark Life Sciences's current dividend yield, its reliability and sustainability?
Dividend Score
3/6Dividend Score 3/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
5.38%
Current Dividend Yield
Dividend Yield vs Market
| Glenmark Life Sciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (543322) | 5.4% |
| Market Bottom 25% (IN) | 0.4% |
| Market Top 25% (IN) | 1.6% |
| Industry Average (Pharmaceuticals) | 0.9% |
| Analyst forecast in 3 Years (543322) | 3.6% |
Notable Dividend: 543322's dividend (5.38%) is higher than the bottom 25% of dividend payers in the Indian market (0.36%).
High Dividend: 543322's dividend (5.38%) is in the top 25% of dividend payers in the Indian market (1.55%)
Stability and Growth of Payments
| Month | Dividend Per Share (annual) | Avg. Yield (%) |
|---|---|---|
| 3/31/2025 | 12.82 | 2 |
| 3/31/2024 | 15.71 | 3 |
| 3/31/2023 | 13.34 | 3 |
| 1/25/2023 | 21 | 5.38 |
| 8/25/2022 | 21 | 5.02 |
| 2/8/2022 | 21 | 4.54 |
| 11/10/2021 | 21 | 3.47 |
Stable Dividend: Too early to tell whether 543322's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 543322's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (30.8%), 543322's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (129.2%), 543322's dividend payments are not well covered by cash flows.